{"id":"NCT04414397","sponsor":"Allergan","briefTitle":"A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old","officialTitle":"A Multicenter, Evaluator-blinded, Randomized, Parallel-group, Controlled Study of the Safety and Effectiveness of JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-05-28","primaryCompletion":"2022-10-17","completion":"2022-10-17","firstPosted":"2020-06-04","resultsPosted":"2024-04-25","lastUpdate":"2024-04-25"},"enrollment":205,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Temple Hollowing"],"interventions":[{"type":"DEVICE","name":"JUVÉDERM® VOLUMA® XC","otherNames":[]},{"type":"OTHER","name":"No-treatment control","otherNames":[]}],"arms":[{"label":"No Treatment then JUVÉDERM® VOLUMA® XC","type":"OTHER"},{"label":"JUVÉDERM® VOLUMA® XC","type":"EXPERIMENTAL"}],"summary":"The objectives of this study are to evaluate the safety and effectiveness of Juvederm® Voluma® XC injectable gel in adult participants seeking correction of temple hollowing","primaryOutcome":{"measure":"Percentage of Participants With ≥ 1-grade Improvement From Baseline in the Validated Allergan Temple Hollowing Scale (ATHS) Based on Evaluating Investigator (EI) Assessment at Month 3","timeFrame":"Baseline, Month 3 (Control Period)","effectByArm":[{"arm":"No Treatment Then JUVÉDERM® VOLUMA® XC","deltaMin":13.5,"sd":null},{"arm":"JUVÉDERM® VOLUMA® XC","deltaMin":80.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"22 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":12},"locations":{"siteCount":15,"countries":["United States","Puerto Rico"]},"refs":{"pmids":[],"seeAlso":["https://www.abbvieclinicaltrials.com/study/?id=1878-702-008"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":59},"commonTop":["HEADACHE","PAIN IN JAW","COVID-19","TRISMUS"]}}